Experienced in Median Arcuate Ligament Syndrome (MALS)

Jaw-yuan H. Wang

Kaohsiung, KHQ, TW 
Experienced in Median Arcuate Ligament Syndrome (MALS)
Kaohsiung, KHQ, TW 
OverviewLocationsClinical Research

Overview

Jaw-yuan Wang practices in Kaohsiung, Taiwan. Wang is rated as an Experienced expert by MediFind in the treatment of Median Arcuate Ligament Syndrome (MALS). Their top areas of expertise are Colorectal Cancer, Xeroderma Pigmentosum, Familial Colorectal Cancer, Endoscopy, and Colonoscopy.

Their clinical research consists of co-authoring 392 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Median Arcuate Ligament Syndrome (MALS).

Locations

Kaohsiung, KHQ, Taiwan
Other Locations
Pingtung, TNQ, Taiwan
Taipei, TNQ 11031, Taiwan
Hualien City, TNQ, Taiwan
TPQ 10051, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Study Comparing the Efficacy and Safety of Tislelizumab (BGB-A317) Plus Platinum and Fluoropyrimidine Versus Placebo Plus Platinum and Fluoropyrimidine as First-Line Treatment in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Enrollment Status: Completed
Publish Date: February 14, 2025
Intervention Type: Drug
Study Phase: Phase 3
Determination of the UGT1A1 Polymorphism as Guidance for Irinotecan Dose Escalation in Metastatic Colorectal Cancer Treated With First-Line Bevacizumab and FOLFIRI (PURE FIST)
Determination of the UGT1A1 Polymorphism as Guidance for Irinotecan Dose Escalation in Metastatic Colorectal Cancer Treated With First-Line Bevacizumab and FOLFIRI (PURE FIST)
Enrollment Status: Completed
Publish Date: November 17, 2021
Intervention Type: Drug, Genetic
Study Phase: Not Applicable
The Efficacy of Silymarin as Adjuvant Therapy on Colorectal Cancer Patients Undergoing FOLFIRI Treatment
The Efficacy of Silymarin as Adjuvant Therapy on Colorectal Cancer Patients Undergoing FOLFIRI Treatment
Enrollment Status: Completed
Publish Date: May 13, 2020
Intervention Type: Drug
Study Phase: Phase 4
A Pilot Study of Home Parenteral Nutrition for Malnourished Patients With Unresectable Stage IV Gastric Receiving Salvage Chemotherapy
A Pilot Study of Home Parenteral Nutrition for Malnourished Patients With Unresectable Stage IV Gastric Receiving Salvage Chemotherapy
Enrollment Status: Completed
Publish Date: June 21, 2019
Intervention Type: Drug, Other
Study Phase: Not Applicable
View 3 Less Clinical Trials

391 Total Publications

Increased autophagy activity suppresses hyperglycemia-related colorectal cancer tumorigenesis both in vitro and in vivo.
Increased autophagy activity suppresses hyperglycemia-related colorectal cancer tumorigenesis both in vitro and in vivo.
Journal: American journal of cancer research
Published: June 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wang's expertise for a condition
ConditionClose
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile